Searched over 200M research papers
10 papers analyzed
These studies suggest the top cholesterol medications include statins, ezetimibe, PCSK9 inhibitors (like evolocumab), fibrates, and niacin.
19 papers analyzed
Statins are the most commonly prescribed medications for lowering cholesterol. They work by inhibiting the enzyme HMG-CoA reductase, which plays a crucial role in the production of cholesterol in the liver. Statins can reduce low-density lipoprotein (LDL) cholesterol by 20% to 45%. The most frequently used statins include simvastatin and atorvastatin, with simvastatin being the most commonly prescribed. Rosuvastatin, another potent statin, is currently the most-prescribed drug in the United States.
Ezetimibe is another important cholesterol-lowering medication that works by inhibiting the absorption of cholesterol in the intestines. It targets the Niemann-Pick C1-like 1 protein (NPC1L1) and can lower LDL cholesterol by about 18% when used alone. When combined with statins, it can further reduce LDL levels by an additional 25%. Ezetimibe has shown significant cardiovascular benefits, particularly when used in combination with statins, as evidenced by the IMPROVE-IT trial.
PCSK9 inhibitors, such as evolocumab and alirocumab, represent a newer class of cholesterol-lowering drugs. These monoclonal antibodies work by preventing the degradation of LDL receptors in the liver, thereby enhancing the liver's ability to remove LDL cholesterol from the blood. Evolocumab can reduce LDL cholesterol by 53% to 56%. Clinical trials like FOURIER and ODYSSEY OUTCOMES have demonstrated the efficacy of PCSK9 inhibitors in reducing cardiovascular events.
Niacin, also known as vitamin B3, has been used to increase high-density lipoprotein (HDL) cholesterol and lower LDL cholesterol. It can reduce LDL cholesterol by 14% and increase HDL cholesterol by 16%. However, recent studies have shown limited cardiovascular benefits when niacin is added to statin therapy, and it is associated with side effects such as flushing .
Fibrates are another class of lipid-lowering drugs that primarily reduce triglycerides and increase HDL cholesterol. They can reduce major coronary events by 25% and are generally well-tolerated. Although not as effective as statins in lowering LDL cholesterol, fibrates are beneficial for patients with high triglycerides and low HDL cholesterol levels.
The top five cholesterol medications include statins, ezetimibe, PCSK9 inhibitors, niacin, and fibrates. Statins remain the cornerstone of cholesterol-lowering therapy due to their efficacy and extensive use. Ezetimibe and PCSK9 inhibitors offer additional benefits, especially for patients who do not achieve optimal LDL levels with statins alone. Niacin and fibrates provide alternative options, particularly for managing HDL and triglyceride levels. Combining these medications can enhance lipid-lowering effects and improve cardiovascular outcomes.
Most relevant research papers on this topic